# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-10-000310
Filing Date
2010-01-26
Accepted
2010-01-26 09:27:05
Documents
9
Period of Report
2009-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | a2196017z20-f.htm | 20-F | 5894592
2 | EXHIBIT 1.1 | a2196017zex-1_1.htm | EX-1.1 | 222375
3 | EXHIBIT 1.2 | a2196017zex-1_2.htm | EX-1.2 | 201981
4 | EXHIBIT 12.1 | a2196017zex-12_1.htm | EX-12.1 | 13824
5 | EXHIBIT 12.2 | a2196017zex-12_2.htm | EX-12.2 | 13562
6 | EXHIBIT 13.1 | a2196017zex-13_1.htm | EX-13.1 | 8938
7 | EX-14.1 | a2196017zex-14_1.htm | EX-14.1 | 9380
8 | G12362KWI001.JPG | g12362kwi001.jpg | GRAPHIC | 4435
9 | G462147.JPG | g462147.jpg | GRAPHIC | 16249
| Complete submission text file | 0001047469-10-000310.txt |  | 6394758

Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-15024 | Film No.: 10546187
SIC: 2834 Pharmaceutical Preparations